Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311573124> ?p ?o ?g. }
- W4311573124 endingPage "e1004124" @default.
- W4311573124 startingPage "e1004124" @default.
- W4311573124 abstract "Background Dementia with Lewy bodies (DLBs) is a common cause of dementia but has higher mortality than Alzheimer’s disease (AD). The reasons for this are unclear, but antidementia drugs (including acetylcholinesterase inhibitors [AChEIs] and memantine) symptomatically benefit people with DLB and might improve outcomes. We investigated whether AChEIs and/or memantine were associated with reduced hospital admissions and mortality. Methods and findings We performed a retrospective cohort study of those diagnosed with DLB between 1 January 2005 and 31 December 2019, using data from electronic clinical records of secondary care mental health services in Cambridgeshire and Peterborough NHS Foundation Trust (CPFT), United Kingdom (catchment area population approximately 0.86 million), as well as linked records from national Hospital Episode Statistics (HES) data. Eligible patients were those who started AChEIs or memantine within 3 months of their diagnosis (cases) and those who never used AChEIs or memantine (controls). Outcomes included admission, length of stay, and mortality. Cox proportional hazard and linear regression models were used. Of 592 patients with DLB, 219 never took AChEIs or memantine, 100 took AChEIs only, and 273 took both AChEIs and memantine. The cohorts were followed up for an average of 896 days, 981 days, and 1,004 days, respectively. There were no significant differences in the cohorts’ baseline characteristics, except for socioeconomic status that was lower in patients who never took AChEIs or memantine ( χ 2 = 23.34, P = 0.003). After controlling for confounding by sociodemographic factors (age, sex, marital status, ethnicity, socioeconomic status), antipsychotic use, antidepressant use, cognitive status, physical comorbidity, anticholinergic burden, and global health performance, compared with patients who never took AChEIs or memantine, patients taking AChEIs only or taking both had a significantly lower risk of death (adjusted hazard ratio (HR) = 0.67, 95% CI = 0.48 to 0.93, p = 0.02; adjusted HR = 0.64, 95% CI = 0.50 to 0.83, P = 0.001, respectively). Those taking AChEIs or both AChEIs and memantine had significantly shorter periods of unplanned hospital admission for physical disorders (adjusted coefficient −13.48, 95% CI = [−26.87, −0.09], P = 0.049; adjusted coefficient −14.21, 95% CI = [−24.58, −3.85], P = 0.007, respectively), but no difference in length of stay for planned admissions for physical disorders, or for admissions for mental health disorders. No significant additional associations of memantine on admission, length of stay, and mortality were found (all P > 0.05). The main limitation was that this was a naturalistic study and possible confounds cannot be fully controlled, and there may be selection bias resulting from nonrandom prescription behaviour in clinical practice. However, we mimicked the intention-to-treat design of clinical trials, and the majority of baseline characters were balanced between cohorts. In addition, our series of sensitivity analyses confirmed the consistency of our results. Conclusion In this study, we observed that use of AChEIs with or without memantine in DLB was associated with shorter duration of hospital admissions and decreased risk of mortality. Although our study was naturalistic, it supports further the use of AChEIs in DLB." @default.
- W4311573124 created "2022-12-27" @default.
- W4311573124 creator A5027987037 @default.
- W4311573124 creator A5041563576 @default.
- W4311573124 creator A5046614170 @default.
- W4311573124 creator A5048502650 @default.
- W4311573124 creator A5066820772 @default.
- W4311573124 creator A5067147989 @default.
- W4311573124 creator A5086184925 @default.
- W4311573124 creator A5086490109 @default.
- W4311573124 creator A5088674945 @default.
- W4311573124 date "2022-12-06" @default.
- W4311573124 modified "2023-10-18" @default.
- W4311573124 title "Association between antidementia medication use and mortality in people diagnosed with dementia with Lewy bodies in the UK: A retrospective cohort study" @default.
- W4311573124 cites W1570622790 @default.
- W4311573124 cites W1682771183 @default.
- W4311573124 cites W1825856938 @default.
- W4311573124 cites W1977427195 @default.
- W4311573124 cites W1999887188 @default.
- W4311573124 cites W2000445173 @default.
- W4311573124 cites W2003278257 @default.
- W4311573124 cites W2018081653 @default.
- W4311573124 cites W2019145949 @default.
- W4311573124 cites W2022914903 @default.
- W4311573124 cites W2044384631 @default.
- W4311573124 cites W2044663741 @default.
- W4311573124 cites W2048470090 @default.
- W4311573124 cites W2048657965 @default.
- W4311573124 cites W2048697939 @default.
- W4311573124 cites W2050028249 @default.
- W4311573124 cites W2061326496 @default.
- W4311573124 cites W2082099550 @default.
- W4311573124 cites W2090156874 @default.
- W4311573124 cites W2106507629 @default.
- W4311573124 cites W2115455636 @default.
- W4311573124 cites W2129147099 @default.
- W4311573124 cites W2137419542 @default.
- W4311573124 cites W2161016232 @default.
- W4311573124 cites W2165181618 @default.
- W4311573124 cites W2165758561 @default.
- W4311573124 cites W2544374136 @default.
- W4311573124 cites W2599038523 @default.
- W4311573124 cites W2608320814 @default.
- W4311573124 cites W2609479105 @default.
- W4311573124 cites W2623521763 @default.
- W4311573124 cites W2645645336 @default.
- W4311573124 cites W2765268397 @default.
- W4311573124 cites W2780842894 @default.
- W4311573124 cites W2796455233 @default.
- W4311573124 cites W2801455203 @default.
- W4311573124 cites W2807524908 @default.
- W4311573124 cites W2895649319 @default.
- W4311573124 cites W2905877181 @default.
- W4311573124 cites W2913037381 @default.
- W4311573124 cites W2928087340 @default.
- W4311573124 cites W3138811377 @default.
- W4311573124 cites W3179853305 @default.
- W4311573124 doi "https://doi.org/10.1371/journal.pmed.1004124" @default.
- W4311573124 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36472984" @default.
- W4311573124 hasPublicationYear "2022" @default.
- W4311573124 type Work @default.
- W4311573124 citedByCount "2" @default.
- W4311573124 countsByYear W43115731242023 @default.
- W4311573124 crossrefType "journal-article" @default.
- W4311573124 hasAuthorship W4311573124A5027987037 @default.
- W4311573124 hasAuthorship W4311573124A5041563576 @default.
- W4311573124 hasAuthorship W4311573124A5046614170 @default.
- W4311573124 hasAuthorship W4311573124A5048502650 @default.
- W4311573124 hasAuthorship W4311573124A5066820772 @default.
- W4311573124 hasAuthorship W4311573124A5067147989 @default.
- W4311573124 hasAuthorship W4311573124A5086184925 @default.
- W4311573124 hasAuthorship W4311573124A5086490109 @default.
- W4311573124 hasAuthorship W4311573124A5088674945 @default.
- W4311573124 hasBestOaLocation W43115731241 @default.
- W4311573124 hasConcept C118552586 @default.
- W4311573124 hasConcept C126322002 @default.
- W4311573124 hasConcept C167135981 @default.
- W4311573124 hasConcept C187212893 @default.
- W4311573124 hasConcept C207103383 @default.
- W4311573124 hasConcept C2776332859 @default.
- W4311573124 hasConcept C2778548049 @default.
- W4311573124 hasConcept C2779134260 @default.
- W4311573124 hasConcept C2779483572 @default.
- W4311573124 hasConcept C2779484449 @default.
- W4311573124 hasConcept C2780904820 @default.
- W4311573124 hasConcept C2908647359 @default.
- W4311573124 hasConcept C44249647 @default.
- W4311573124 hasConcept C71924100 @default.
- W4311573124 hasConcept C72563966 @default.
- W4311573124 hasConcept C99454951 @default.
- W4311573124 hasConceptScore W4311573124C118552586 @default.
- W4311573124 hasConceptScore W4311573124C126322002 @default.
- W4311573124 hasConceptScore W4311573124C167135981 @default.
- W4311573124 hasConceptScore W4311573124C187212893 @default.
- W4311573124 hasConceptScore W4311573124C207103383 @default.
- W4311573124 hasConceptScore W4311573124C2776332859 @default.
- W4311573124 hasConceptScore W4311573124C2778548049 @default.
- W4311573124 hasConceptScore W4311573124C2779134260 @default.